TITLE

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients

AUTHOR(S)
Del Brutto, O H
PUB. DATE
June 1997
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jun1997, Vol. 62 Issue 6, p659
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66068212

 

Related Articles

  • Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel. Del Brutto, Oscar H.; Roos, Karen L.; Coffey, Christopher S.; García, Héctor H. // Annals of Internal Medicine;7/4/2006, Vol. 145 Issue 1, p43 

    Background: Conflicting reports have caused controversy on whether cysticidal drugs modify the natural course of neurocysticercosis. Purpose: To perform a meta-analysis of randomized trials assessing the effect of cysticidal drugs on neuroimaging and clinical outcomes of patients with...

  • Management of neurocysticercosis. Riley, Terrence; White Jr, A.C.; White, A C Jr // CNS Drugs;2003, Vol. 17 Issue 8, p577 

    Neurocysticercosis is a common cause of neurological disease in developing countries and a major cause of epilepsy worldwide. A unique characteristic of human neurocysticercosis is that the living parasite is very well tolerated in human brain, so symptoms and clinical disease primarily result...

  • Transitory alexia without agraphia: A disconnection syndrome due to neurocysticercosis. Verma, Archana; Singh, N.N.; Misra, Surendra // Neurology India;Sep2004, Vol. 52 Issue 3, p378 

    We describe a 65-year-old male who presented with acute onset inability to read, without any difficulty in writing. A clinical diagnosis of alexia without agraphia was made and the patient was subjected to routine investigations including contrast MRI. MRI showed a ring-enhancing lesion in left....

  • Clinico-radiological profile and treatment outcomes in neurocysticercosis: A study of 40 patients. Patil, Tushar B.; Paithankar, Madhuri M. // Annals of Tropical Medicine & Public Health;Mar/Apr2012, Vol. 5 Issue 2, p63 

    Aims: This study was aimed to study the clinical and radiological profile of neurocysticercosis and outcomes of treatment in neurocysticercosis. Settings and Design: A prospective observational study in a tertiary care hospital. Methods and Material: A total of 40 patients coming under...

  • Neurocysticercosis: The Enigmatic Disease. Agapejev, Svetlana // Central Nervous System Agents in Medicinal Chemistry;Dec2011, Vol. 11 Issue 4, p261 

    Neurocysticercosis (NCC) is an infection of the central nervous system (CNS) caused by the metacestode larval form of the parasite Taenia sp. Many factors can contribute to the endemic nature of cysticercosis. The inflammatory process that occurs in the tissue surrounding the parasite and/or...

  • Reversible cardiogenic shock complicating subarachnoid haemorrhage. Parr, Michael J.A.; Finfer, Simon R. // BMJ: British Medical Journal (International Edition);9/14/96, Vol. 313 Issue 7058, p681 

    Discusses the clinical management of a subarachnoid hemorrhage compounded by reversible cardiogenic shock. Case studies; Incidence of patient survival; Analysis of the effectiveness of treatment modes utilized.

  • A Meta-analysis of the Effectiveness of Albendazole Compared with Metronidazole as Treatments for Infections with Giardia duodenalis. Solaymani-Mohammadi, Shahram; Genkinger, Jeanine M.; Loffredo, Christopher A.; Singer, Steven M. // PLoS Neglected Tropical Diseases;May2010, Vol. 4 Issue 5, p1 

    Background: Metronidazole is the most commonly used drug for the treatment of giardiasis in humans. In spite of its therapeutic efficacy for giardiasis, low patient compliance, especially in children, side effects, and the emergence of metronidazole-resistant strains may restrict its use....

  • A Meta-analysis of the Effectiveness of Albendazole Compared with Metronidazole as Treatments for Infections with Giardia duodenalis. Solaymani-Mohammadi, Shahram; Genkinger, Jeanine M.; Loffredo, Christopher A.; Singer, Steven M. // PLoS Clinical Trials;May2010, Vol. 7 Issue 5, p1 

    Background: Metronidazole is the most commonly used drug for the treatment of giardiasis in humans. In spite of its therapeutic efficacy for giardiasis, low patient compliance, especially in children, side effects, and the emergence of metronidazole-resistant strains may restrict its use....

  • Pharmacokinetic Optimisation of the Treatment of Neurocysticercosis. Sotelo, J.; Jung, H. // Clinical Pharmacokinetics;1998, Vol. 34 Issue 6, p503 

    Neurocysticercosis is the most important parasitic infection of the nervous system. It is common in communities living in conditions with poor hygiene. Until the last 2 decades, there was no specific pharmacological treatment: surgery and corticosteroids were the only medical alternatives. The...

  • Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series. Cárdenas, Graciela; Carrillo-Mezo, Roger; Jung, Helgi; Sciutto, Edda; Soto Hernandez, Jose Luis; Fleury, Agnès // BMC Neurology;2010, Vol. 10, p16 

    Background: Neurocysticercosis (NC) is one of the most frequent parasitic diseases of the central nervous system. Cysticidal drugs, albendazole and praziquantel, are generally effective when parasites localize in the parenchyma. In contrast, parasites lodged in the subarachnoid basal cisterns...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics